Randomized clinical trial of acetazolamide administration and/or prone positioning in mitigating wound complications

Shima Shahjouei1, Sara Hanaei1, Zohreh Habibi1

  • 1Department of Neurosurgery, Children's Hospital Medical Center, and.

Insights

Postoperative prone positioning may reduce complications like CSF leakage and collection in pediatric tethered cord syndrome (TCS) patients after spinal untethering surgery. Acetazolamide did not show significant benefits and had side effects.

Area of Science:

  • Neurosurgery
  • Pediatric Surgery
  • Clinical Trials

Background:

  • No established evidence-based guidelines exist for managing pediatric patients post-spinal cord untethering surgery for tethered cord syndrome (TCS).
  • Postoperative complications can significantly impact patient outcomes and recovery following these procedures.

Purpose of the Study:

  • To evaluate the effectiveness of prone positioning and acetazolamide administration in reducing complication rates after spinal cord untethering surgery in pediatric TCS patients.
  • To compare outcomes between four groups: acetazolamide, prone positioning, combined therapy, and no intervention.

Main Methods:

  • A randomized clinical trial involving 161 pediatric patients diagnosed with TCS.
  • Patients were randomly assigned to receive postoperative acetazolamide, prone positioning, both, or no intervention for 10 days.
  • Key failure outcomes included cerebrospinal fluid (CSF) leakage, CSF collection, wound dehiscence, surgical site infection, and secondary wound repair.

Main Results:

  • The overall complication rate was 12.42%. Specific complications included CSF leakage (5.6%), CSF collection (7.5%), wound dehiscence (1.2%), and infection (1.9%).
  • Prone positioning significantly reduced rates of CSF leakage (p=0.042) and CSF collection (p=0.036).
  • Acetazolamide, alone or combined with prone positioning, did not significantly lower complication rates and was associated with side effects.

Conclusions:

  • Prone positioning appears to be a beneficial intervention for reducing postoperative complications, specifically CSF leakage and collection, in pediatric patients undergoing spinal cord untethering for TCS.
  • Acetazolamide administration is not recommended for routine postoperative management in this patient population due to lack of efficacy and potential side effects.
  • Clinical trial registration: NCT01867268.

Related Concept Videos